Table 5.
Clinical characteristics and results of statistical analyses.
| Clinical scores |
Clinical scores: mean (std. dev.) |
Omnibus F value; p value |
Pairwise comparisons (p < 0.05) |
|||||
|---|---|---|---|---|---|---|---|---|
| baseline | pre- intervention |
post- intervention |
follow-up | baseline vs. post |
pre vs. post |
pre vs. follow-up |
||
| UPDRS – I | 0.9 (1.0) | 0.5 (0.6) | 0.5 (1.36) | 0.8 (1.0) | 0.72; 0.55 | |||
|
| ||||||||
| UPDRS – II | 7.1 (3.6) | 7.1 (3.8) | 6.9 (3.2) | 6.6 (3.7) | 1.14; 0.79 | |||
|
| ||||||||
| UPDRS – III | 15.9 (8.0) | 14.5 (7.4) | 11.8 (9.6) | 11.9 (8.2) | 5.92; 0.01 | p=0.002 | p = 0.028 | |
|
| ||||||||
| UPDRS Total | 23.9 (10.6) | 22.1 (9.9) | 19.1 (12.1) | 19.1 (11.8) | 3.66; 0.06 | p=0.002 | ||
|
| ||||||||
| UPDRS Axial | 6.4 (3.8) | 6.0 (4.1) | 4.6 (3.4) | 5.2 (4.0) | 8.06; < 0.001 | p = 0.045 | ||
|
| ||||||||
| UPDRS – GB | 4.4 (2.3) | 3.9 (2.5) | 2.5 (2) | 2.9 (2.2) | 10.44; < 0.001 | p = 0.022 | p = 0.034 | |
|
| ||||||||
| H&Y | 2.8 (0.3) | 2.8 (0.3) | 2.3 (0.5) | 2.4 (0.4) | 19.28; < 0.001 | p=0.001 | p < 0.001 | p = 0.009 |
|
| ||||||||
| PDQ-39 | 36.8 (23.7) | 30.0 (18.7) | 32.6 (19.8) | 25.1 (13.0) | 2.76; 0.05 | |||